CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $14,416,682 | +64.7% | 375,239 | -0.8% | 0.00% | +33.3% |
| Q1 2023 | $8,753,640 | -12.9% | 378,127 | -1.5% | 0.00% | 0.0% |
| Q4 2022 | $10,053,254 | +36.5% | 383,712 | +2.5% | 0.00% | 0.0% |
| Q3 2022 | $7,363,000 | +164.0% | 374,487 | +134.9% | 0.00% | +200.0% |
| Q2 2022 | $2,789,000 | +52.9% | 159,412 | +43.0% | 0.00% | 0.0% |
| Q1 2022 | $1,824,000 | +9.5% | 111,475 | +9.2% | 0.00% | – |
| Q4 2021 | $1,666,000 | +54.3% | 102,101 | +20.7% | 0.00% | – |
| Q3 2021 | $1,080,000 | -4.4% | 84,600 | +5.8% | 0.00% | – |
| Q2 2021 | $1,130,000 | +76.3% | 79,991 | +94.1% | 0.00% | – |
| Q1 2021 | $641,000 | -2.0% | 41,217 | +0.0% | 0.00% | – |
| Q4 2020 | $654,000 | – | 41,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $135,241,466 | 29.11% |
| Octagon Capital Advisors LP | 2,551,703 | $66,854,619 | 10.41% |
| Affinity Asset Advisors, LLC | 818,035 | $21,432,517 | 8.40% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $113,853,646 | 7.08% |
| Saturn V Capital Management LP | 423,177 | $6,728,298 | 5.58% |
| Altium Capital Management LP | 385,000 | $10,087,000 | 5.13% |
| Deep Track Capital, LP | 3,000,000 | $78,600,000 | 3.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 340,389 | $8,914,788 | 2.75% |
| Vivo Capital, LLC | 872,151 | $22,850 | 2.63% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,985,490 | 2.06% |